Cross-sectional study investigates brain-predicted age gap and volume differences in multiple sclerosis patients, suggesting neurodegenerative impacts.
The aim of this study is to investigate brain-predicted age, brain-predicted age gap (the difference between brain-predicted age and chronological age), and brain tissue volume changes in Multiple Sclerosis (MS) patients compared to healthy controls (HCs) to better understand and characterize the neurodegenerative burden of the disease.
No takes yet. Share an insight, caveat, or question.
Bao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: